Skip to main content
. 2009 Dec 23;24(2):359–369. doi: 10.1210/me.2009-0346

Figure 3.

Figure 3

AhR agonists inhibit invasiveness of human breast cancer cells. A, Invasiveness of SKBR3 cells after 24-h exposure to vehicle (Veh) or multiple AhR ligands (TCDD, 10 nm; TCBDF, 10 nm; and DIM, 20 μm) and the AhR antagonist α-NF. Graphic data are represented as percent of Veh control (set at 100%). B, Invasiveness of MDA MB-231 cells after 24-h exposure to Veh or TCDD (10 nm). C, Invasiveness of MCF-7 cells after 24-h exposure to Veh or multiple AhR ligands (TCDD, 10 nm; TCBDF, 10 nm; and DIM, 20 μm) and the AhR antagonist α-NF in the presence and absence of 10 nm E2. D, Invasiveness of ZR-75-1 cells after 24-h exposure to Veh or TCDD (10 nm) in the presence and absence of 10 nm E2. For panels A–D, n = 3–4 independent assays, and bars are mean ± sd. *, P < 0.05 compared to vehicle.